Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive effect against a ...

Immutep shares update on Phase I study of LAG-3 agonist antibody for autoimmune diseases, showing positive safety & efficacy ...

The MarketWatch News Department was not involved in the creation of this content.-- Windward Bio and Qyuns Therapeutics announce licensing agreement for WIN027, a highly potent, l ...

In 2025, Anthropic will grow from $1 billion to $9 billion in ARR (annual recurring revenue). OpenAI, meanwhile, will go from ...

The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced today that it has resubmitted the MOLBREEVI BLA to the FDA, with ...

Mondego Bio, a clinical-stage biotechnology company developing next-generation small-molecule immuno-oncology therapies, today announced the formal selection of its lead clinical candidate, ZE00-0388, ...

As customer acquisition costs (CAC) continue to rise, AI-native SaaS companies are facing growing pressure to convert demand into durable, recurring revenue. Subotiz, a next-generation subscription ...

Artificial intelligence has just helped virologists pull off something that used to take years of trial and error: crippling ...

Medically reviewed by Suzanne Fisher, RDVitamin B6 deficiency can cause mental health symptoms, skin rashes, and sores, or cracks on the mouth or tongue.More serious symptoms of low B6 levels include ...

Researchers at the Massachusetts Institute of Technology and Stanford University have reported a novel immunotherapy strategy that targets sugar-based immune checkpoints on tumour cells, with the ...